106
Participants
Start Date
December 19, 2022
Primary Completion Date
June 30, 2024
Study Completion Date
June 30, 2024
Radiopharmaceutical 18F-JK-PSMA-7
"The Investigational product 18F-JK-PSMA-7 is a diagnostic radiopharmaceutical for use with positron emission tomography.~18F-JK-PSMA-7 is administered as direct intravenous injection. One single administration of 2-4 MBq/kg of 18F-JK-PSMA-7 is scheduled in each patient included in this study."
Radiopharmaceutical 18F-Fluorocholine
"The active substance of Comparator is 18F-Fluorocholine. The Comparator will be a 18F-Fluorocholine with a Marketing Authorisation in Italy that will be used in compliance with its Summary of Product Characteristics (SmPC).~18F-Fluorocholine is administrated as direct intravenous injection. One single administration of 18F-Fluorocholine is scheduled in each patient included in this study."
I.R.S.T. Srl Irccs, Meldola
Ospedale Classificato Sacro Cuore - Don Calabria, Negrar
Advice Pharma Group srl
INDUSTRY
ITEL Telecomunicazioni Srl
INDUSTRY